Business Description
BioVie Inc
NAICS : 325412
SIC : 2834
ISIN : US09074F1084
Share Class Description:
BIVI: Ordinary Shares - Class ADescription
BioVie Inc is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.97 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.37 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.9 | |||||
| 3-Year EPS without NRI Growth Rate | 32.9 | |||||
| 3-Year FCF Growth Rate | -55.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.2 | |||||
| 9-Day RSI | 40.24 | |||||
| 14-Day RSI | 38.06 | |||||
| 6-1 Month Momentum % | -83.56 | |||||
| 12-1 Month Momentum % | -92.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 1.47 | |||||
| Cash Ratio | 1.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -91.3 | |||||
| Shareholder Yield % | -77.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -276.75 | |||||
| ROA % | -125.24 | |||||
| ROIC % | -419.49 | |||||
| ROC (Joel Greenblatt) % | -48696.03 | |||||
| ROCE % | -182.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.58 | |||||
| Price-to-Tangible-Book | 2.88 | |||||
| EV-to-EBIT | -0.42 | |||||
| EV-to-EBITDA | -0.42 | |||||
| EV-to-FCF | -0.41 | |||||
| Price-to-Net-Current-Asset-Value | 3.06 | |||||
| Price-to-Net-Cash | 3.06 | |||||
| Earnings Yield (Greenblatt) % | -238.1 | |||||
| FCF Yield % | -152.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BIVI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioVie Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.17 | ||
| Beta | 0.74 | ||
| Volatility % | 98.96 | ||
| 14-Day RSI | 38.06 | ||
| 14-Day ATR ($) | 0.057862 | ||
| 20-Day SMA ($) | 0.49213 | ||
| 12-1 Month Momentum % | -92.42 | ||
| 52-Week Range ($) | 0.445 - 8.69 | ||
| Shares Outstanding (Mil) | 54.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioVie Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioVie Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioVie Inc Frequently Asked Questions
What is BioVie Inc(BIVI)'s stock price today?
The current price of BIVI is $0.49. The 52 week high of BIVI is $8.69 and 52 week low is $0.45.
When is next earnings date of BioVie Inc(BIVI)?
The next earnings date of BioVie Inc(BIVI) is 2024-05-12 Est..
Does BioVie Inc(BIVI) pay dividends? If so, how much?
BioVie Inc(BIVI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers